| Literature DB >> 22461843 |
Adriano Guimarães-Santos1, Diego Siqueira Santos, Ijair Rogério Santos, Rafael Rodrigues Lima, Antonio Pereira, Lucinewton Silva de Moura, Raul Nunes Carvalho, Osmar Lameira, Walace Gomes-Leal.
Abstract
The oil-resin of Copaifera reticulata Ducke is used in the Brazilian folk medicine as an anti-inflammatory and healing agent. However, there are no investigations on the possible anti-inflammatory and neuroprotective roles of copaiba oil-resin (COR) after neural disorders. We have investigated the anti-inflammatory and neuroprotective effects of COR following an acute damage to the motor cortex of adult rats. Animals were injected with the neurotoxin N-Methyl-D-Aspartate (NMDA) (n = 10) and treated with a single dose of COR (400 mg/kg, i.p.) soon after surgery (Group 1) or with two daily doses (200 mg/kg, i.p.) during 3 days (Group 2) alter injury. Control animals were treated with vehicle only. COR treatment induced tissue preservation and decreased the recruitment of neutrophils and microglial activation in the injury site compared to vehicle animals. The results suggest that COR treatment induces neuroprotection by modulating inflammatory response following an acute damage to the central nervous system.Entities:
Year: 2012 PMID: 22461843 PMCID: PMC3291111 DOI: 10.1155/2012/918174
Source DB: PubMed Journal: Evid Based Complement Alternat Med ISSN: 1741-427X Impact factor: 2.629
Composition of the copaiba's oleoresin used in the present study revealed by gas chromatography.
| Component | Percentage (%) |
|---|---|
|
| 0.2 |
| cyclosativene | 0.9 |
|
| 0.5 |
|
| 0.2 |
| cyclosativene | 0.9 |
|
| 0.5 |
|
| 3.2 |
|
| 0.7 |
|
| 37.3 |
|
| 9.0 |
| aromadendrene | 0.9 |
|
| 0.1 |
|
| 5.4 |
|
| 1.0 |
|
| 0.6 |
|
| 0.6 |
|
| 4.8 |
|
| 3.0 |
| (Z)- | 1.8 |
|
| 2.2 |
|
| 14.5 |
|
| 0.4 |
|
| 1.2 |
| (E)- | 1.4 |
| caryophyllene oxide | 0.1 |
|
| 0.1 |
|
| 0.2 |
Figure 1COR treatment effects on gross histopathology at 1 day following NMDA injection into the rat motor cortex, as revealed by cresyl violet staining. Animals treated with 5% tween (a-b) or 400 mg/kg of COR (c-d). COR treatment reduced polymorphonuclear cell infiltration and tissue loss (c-d) compared to vehicle animals (a-b). Arrows point to polymorphonuclear cells (d). Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
Figure 2COR treatment reduces neutrophil infiltration at 1 day following cortical damage, as revealed by antineutrophil immunohistochemistry. Animals treated with 5% tween (a-b) or 400 mg/kg of COR (c-d). COR treatment reduced neutrophil infiltration (c-d) compared to vehicle animals (a-b), as confirmed by quantitative analysis (e, P < 0.01, Student's t-test). Arrows point to MBS-1+ cells (neutrophils). Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
Figure 3COR treatment effects on gross histopathology at 4 days following NMDA injection into the rat motor cortex, as revealed by cresyl violet staining. Animals treated with 5% tween (a-b) or 400 mg/kg of COR (c-d). COR treatment reduced mononuclear cell infiltration and tissue cavitation (c-d) compared to vehicle animals (a-b). Arrows point to mononuclear cells (d). Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).
Figure 4COR treatment reduces mononuclear cell infiltration at 4 days following cortical damage, as revealed by anti-ED1 immunohistochemistry. Animals treated with 5% tween (a-b) or 400 mg/kg of COR (c-d). COR treatment reduced microglia/macrophage activation (ED1+ cells) (c-d), compared to vehicle animals (a-b), as confirmed by quantitative analysis (e, P < 0.01, Student's t-test). Arrows point to ED1+ cells (activated microglia/macrophages). Asterisks indicate the excitotoxic necrotic center. Scale bars: (a–c) (300 μm); (b–d) (50 μm).